214450.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 02:30):

Stats
Today's Volume	185 177
Average Volume	155 235
Market Cap	1 211.81B
EPS	KRW0 ( 2024-03-20 )
Next earnings date	( KRW2 231.12 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW345.05 (0.29%)

Volume Correlation

Long: 0.66 (moderate)

Short: 0.45 (neutral)

Signal:(76.854) Neutral

PharmaResearch Co., Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaResearch Co., Ltd. Correlation - Currency/Commodity

0.35
( neutral )

0.59
( weak )

-0.07
( neutral )

0.64
( weak )

0.01
( neutral )

-0.70
( moderate negative )

PharmaResearch Co., Ltd. Financials

Annual	2023
Revenue:	KRW261.01B
Gross Profit:	KRW182.26B (69.83 %)
EPS:	KRW7 571.24

FY	2023
Revenue:	KRW261.01B
Gross Profit:	KRW182.26B (69.83 %)
EPS:	KRW7 571.24

FY	2022
Revenue:	KRW194.76B
Gross Profit:	KRW134.13B (68.87 %)
EPS:	KRW4 067.47

Financial Reports:

No articles found.

PharmaResearch Co., Ltd.

PharmaResearch Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; Rejuvenex cream, which treats the wound through rapid tissue regeneration; REJURAN HEALER, an intra dermal injection to enhance elasticity, turgidity, and tonicity of skin; Rejuran i and Rejuran s intra dermal or cannula injections; REJURAN moisturizer for daily skin protection; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel; REJURAN healing cream and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. It also provides D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; and CLEVIEL prime plus and contour plus with lidocaine medical devices, as well as CONJURAN medical devices. In addition, the company offers functional foods under the REJULINE, REJUSHINE, and REJULIGHT brands. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Seongnam, South Korea.